Harmony Biosciences Holdings (HRMY) Inventory (2019 - 2026)

Harmony Biosciences Holdings (HRMY) has 8 years of Inventory data on file, last reported at $5.3 million in Q1 2026.

• For the quarter ending Q1 2026, Inventory fell 17.28% year-over-year to $5.3 million; the trailing twelve-month figure through Mar 2026 stood at $5.3 million (down 17.28% YoY), and the FY2025 full-year result was $5.5 million, down 23.3% from the prior year.
• Inventory retreated to $5.3 million in Q1 2026, from $5.5 million in the prior quarter.
• In the past five years, Inventory ranged from a high of $7.2 million in Q4 2024 to a low of $4.2 million in Q2 2022.
• A 5-year average of $5.6 million and a median of $5.4 million in 2023 frame the typical range for Inventory.
• Across the five-year window, Inventory soared 35.93% in 2024 and fell 23.3% in 2025, its largest moves.
• Tracing HRMY's Inventory over 5 years: stood at $4.9 million in 2022, then grew by 9.09% to $5.4 million in 2023, then soared by 34.22% to $7.2 million in 2024, then slipped by 23.3% to $5.5 million in 2025, then fell by 4.35% to $5.3 million in 2026.
• Business Quant data shows HRMY's Inventory at $5.3 million in Q1 2026, $5.5 million in Q4 2025, and $7.0 million in Q3 2025.